2026. The Impact of CYP2C9 Rs1057910 and rs1799853 Polymorphism on the Effectiveness of Glibenclamide in T2DM Iraqi Patients. Genetics and Molecular Research. 25, 1 (Jan. 2026), 1–25. DOI:https://doi.org/10.4238/1fvw5h08.